By analysing immune responses across people of different ages after seasonal influenza vaccination, immunologists at the Babraham Institute have shown that a particular type of white blood cell, circulating T follicular helper cells, is linked with good influenza antibody responses in younger people. But that in people over 65, the formation of these cells upon vaccination is reduced compared...
Babraham Institute

The Institute is an independent charitable life sciences research institute, strategically funded by the Biotechnology and Biological Sciences Research Council.
The Institute undertakes world-leading, innovative research and advanced training with relevance to the biomedical, biotechnological, pharmaceutical and healthcare communities. Our research is centred around understanding how our bodies work and what changes as we age and with disease.The Institute's three research programmes bring together research leaders in epigenetics, cell signalling and immunology and the Institute's research is underpinned by nine cutting-edge science facilities. The Institute is a partner of the Barbaham Research Campus, operarted by Babraham Bioscience Technologies Ltd, and commercialisation of the Institute's research is managed by its wholly-owned trading subsidiary, Babraham Institute Enterprise (BIE).
There are no Products & Services to display

Professor Adrian Liston, Senior Group Leader at the Babraham Institute, and artist Dr Sonia Agüera-Gonzalez have published a captivating story book to teach children about the immune system and why vaccinations are important.

Babraham Research Campus Ltd, which develops and manages the Babraham Research Campus, and the Babraham Institute have secured funding for 15 PhD studentships from UKRI-BBSRC as part of a Collaborative Training Partnership (CTP). Through a tailored programme of skills training and scientific and industry supervision, the partnership will produce a cohort of bioscience researchers equipped with...

Dr Ian McGough is the first of four new group leaders to join the Babraham Institute in positions split across, and in some cases bridging, the Institute's Signalling and Epigenetics research programmes.

The Babraham Institute welcomes the Babraham Research Campus strategy to develop the Campus into “one of the best places in the world for discovery bioscience research and innovation.”

Following an open and international search, Professor Wolf Reik has been appointed by the Babraham Institute Board of Trustee Directors as the Institute’s Director. Professor Reik has held the position of Acting Director since May 2020 following the tragic death of Professor Michael Wakelam.

The Babraham Institute has recently made four new appointments to the Institute’s Board of Trustees.

Enhanc3D Genomics, a functional genomics spinout company from The Babraham Institute (Cambridge, UK), is pleased to announce that Dr Frank M Armstrong has been appointed as Chair of the Board of Directors of the Company with effect from 4 January 2021.

Professor Wolf Reik has been appointed Acting Director of the Babraham Institute with immediate effect, following the sad loss of Professor Michael Wakelam at the end of March.

Immunology expertise has combined with beautifully evocative illustrations to create an engaging book for children and their parents. A new children’s book ‘Battle Robots of the Blood’ has been launched, available as an e-book for free during the coronavirus lockdown.

The Babraham Institute is devastated to announce the news of the death of Professor Michael Wakelam, the Institute’s Director.

Dr Maria Christophorou joins the Institute as a group leader in the Epigenetics research programme.

Pioneering research by Professor Adrian Liston, a senior group leader at the Babraham Institute, will be developed towards being market-ready for the treatment of brain injury by funding provided by an ERC (European Research Council) Proof of Concept grant.

Dr Michelle Linterman, a group leader in the Babraham Institute’s Immunology research programme, has received a prestigious Lister Institute Research Prize Fellowship.

Researchers design a machine learning algorithm with ~90% accuracy in identifying children with arthritis using blood samples alone, creating a potential diagnostic tool to improve diagnosis and treatment.

Single cell analysis reveals details of heterogeneity in stem cell populations and how naive cells become primed for differentiation. Research also identified a new intermediate cell population showing characteristics of naïve and primed human embryonic stem cells which might be present in the early human embryo.

Immunology researchers at the Babraham Institute have uncovered how lung tissue is remodelled to support an immune response to influenza. If the research findings can be applied to the development of the seasonal influenza vaccination, the result would be more robust protection against multiple influenza strains. Findings are also relevant to understanding a variety of autoimmune diseases and...

We can think of the egg and sperm as information capsules with stored instructions for starting a new life, but post fertilisation, what kick starts the interpretation of these instructions?

The Institute is delighted to have joined both the Equality, Diversity and Inclusion in Science and Health (EDIS) coalition and the Stonewall Diversity Champions programme for embedding LGBT inclusion.

Community-developed blueprint of worm metabolism holds promise for greater understanding of ageing.
Pages
There are no events to display
There are no jobs to display
No Blog articles found